Literature DB >> 6323808

Presence of Epstein-Barr virus DNA in carcinomas of the palatine tonsil.

B Brichácek, I Hirsch, O Síbl, E Vilikusová, V Vonka.   

Abstract

The presence of Epstein-Barr virus genetic material was demonstrated in thin sections of biopsy specimens in 6 of 7 carcinomas of human palatine tonsil by the in situ hybridization test. The biopsy specimens from 4 tonsillar carcinomas exhibited a strong positive reaction; two biopsy specimens were weakly positive. Two tumor-free biopsy specimens were negative. None of the thin sections reacted with 3H-labeled herpes simplex virus DNA probe.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323808

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  7 in total

1.  In situ detection of Epstein Barr virus in gastric carcinoma tissue in China high-risk area.

Authors:  Rong Wan; Mei-Qin Gao; Ling-Yun Gao; Bi-Feng Chen; Qian-Kun Cai
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

Review 2.  Genotypic mapping of HPV and assessment of EBV prevalence in endocervical lesions.

Authors:  J J O'Leary; R J Landers; M Crowley; I Healy; W F Kealy; J Hogan; C Cullinane; P Kelehan; C T Doyle
Journal:  J Clin Pathol       Date:  1997-11       Impact factor: 3.411

3.  Detection of human papillomavirus type 16 DNA in carcinomas of the palatine tonsil.

Authors:  G Niedobitek; S Pitteroff; H Herbst; P Shepherd; T Finn; I Anagnostopoulos; H Stein
Journal:  J Clin Pathol       Date:  1990-11       Impact factor: 3.411

4.  Epstein-Barr virus in normal, pre-malignant, and malignant lesions of the uterine cervix.

Authors:  R J Landers; J J O'Leary; M Crowley; I Healy; P Annis; L Burke; D O'Brien; J Hogan; W F Kealy; F A Lewis
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

5.  Epstein-Barr virus infection in carcinoma of the salivary gland.

Authors:  N Raab-Traub; P Rajadurai; K Flynn; A P Lanier
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

6.  Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders.

Authors:  B Z Katz; U Saini
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

Review 7.  Immune deficiency as a risk factor in Epstein-Barr virus-induced malignant diseases.

Authors:  D T Purtilo; M Okano; H L Grierson
Journal:  Environ Health Perspect       Date:  1990-08       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.